Skip to main content

Decision aids in serious illness: dissemination strategy, anyone?

An example decision aid in serious illness: Prepare, www.prepareforyourcare.org

by: Alex Smith, @AlexSmithMD

I was fortunate to be part of a really nice systematic review of decision aids for patients with serious illness by Adrian Austin (senior author Laura Hanson).  This manuscript was published online ahead of print in JAMA: Internal Medicine last week.

For this study, Austin reviewed nearly 10,000 titles to identify 38 rigorous studies that meet inclusion criteria.  Seventeen were randomized controlled trials.

I'm not going to summarize the article here - suffice it to say there are a number of very promising decision aids to help people with serious illness.  The article is self explanatory, and I highly recommend that people at a minimum look at the tables to see if there are decision aids you might like to incorporate into your practice. Note, you have to be a JAMA: Internal Medicine subscriber to read the article.

I'd like to pose a question, raised in part by James Tulsky in his terrific accompanying editorial.  James says:
Hospitals and health care systems must make the commitment to introduce such tools at the point of care to ensure that patients facing decisions have the resources they need when they need them. Most of the tools reviewed by Austin et al are free and could be disseminated relatively inexpensively.
Emailing with Laura Hanson and Rebecca Sudore after the paper was accepted, we were at a loss as to what the next steps should be for dissemination.  In many ways, we are at a similar point to where we were after conducting a systematic review of prognostic indices for older adults.  We decided (spurred by Lindsey Yourman) to put the prognostic indices in our review online - voila!  ePrognosis.

But these decision aid tools differ from prognostic indices in important respects. Several include booklets.  While many are free, others are proprietary videos that must be purchased.  A few do not appear to be publicly available at all.  These are not as amenable to a website compendium or toolkit, like ePrognosis.

The problem is that busy clinicians will not use these tools unless they are easily available.   Putting them in one place, or linking them somehow, makes a tremendous amount of sense.

So my question for you - does anyone have a dissemination strategy for decision aids in serious illness?

Comments

Kquotes Com said…
very nice blog post. www.kquotes.com
Joshua Uy said…
Here are some random thoughts
Direct to consumer advertising w/access to an online warehouse (like guidelines.gov)
Make it a mandatory reporting requirement like BB for CHF or asa for MI, and then report it
Give people $ off their copays if they use one
Give docs extra money if they use one (i.e. give it it's own CPT code like vaccine administration but decision aid administration) or penalizing it's use
Make it a requirement for specific procedures like a palliative consult before LVAD's.

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…

Palliative Care in Nursing Homes: Discussion of a Multinational Trial with Lieve Van den Block

Nursing homes are a tough place to do palliative care.  There is extremely high staff turnover, physicians are often not present except for the occasional monthly visit, many residents die with untreated symptoms usually after multiple hospitalizations and burdensome life-prolonging treatments, and specialty palliative care - well that is nowhere to be found in most nursing homes outside of hospice.  So what can we do to improve the palliative care outlook in nursing homes?

On todays podcast we talk with Lieve Van den Block about her recent palliative care intervention that was published in JAMA IM this week.  Lieve led a multicomponent intervention to integrate basic nonspecialist palliative care in in 78 nursing homes located in 7 different European countries.  Just take a moment to grasp the size of this study - 7 counties, 78 nursing homes.  I struggle with just trying to improve palliative care in one site!

We discuss with Lieve the results of the study, her take on why they got…